Diazyme Laboratories, Inc.

Diazyme Laboratories, Inc. is a biotechnology and healthcare company founded in 2000 with the slogan "Innovations in Clinical Diagnostics." The company is based in United States and is dedicated to developing diagnostic reagents using proprietary enzyme technologies. These reagents can be conveniently utilized on most automated chemistry analyzers, offering user-friendly formats to healthcare professionals. Diazyme Laboratories' product portfolio encompasses test kits for diagnosing a range of health conditions, including cardiovascular disease, liver disease, cancer markers, renal disease, and electrolyte imbalances. The company operates from its headquarters in Poway, California, and stands out as a cGMP and ISO 13485 certified medical device manufacturer, ensuring high-quality products for the market. With a focus on advancing clinical diagnostics, Diazyme Laboratories has likely attracted interest from venture capitalists. However, specific details about its last investment and the involved investors are currently unavailable. Despite this, the company's innovative approach and its commitment to addressing critical healthcare needs position it as a potential prospect for venture capital investment, particularly in the rapidly evolving biotechnology and healthcare industries.